Foresite Capital Management V, LLC

Insider Reports History

Entity
Company
Location
900 Larkspur Landing Circle, Suite 150, Larkspur, CA
Signature
FORESITE CAPITAL MANAGEMENT V, LLC, By: /s/ James B. Tananbaum, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Foresite Capital Management V, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALUMIS INC. 10%+ Owner Common Stock 4.2M $67.2M $16.00 Jul 1, 2024 Indirect
PARDES BIOSCIENCES, INC. 10%+ Owner Common Stock 13.6M $20.4M $1.50 Apr 5, 2023 Indirect
Theseus Pharmaceuticals, Inc. 10%+ Owner Common Stock 1.39M $4.23M $3.05 Jul 17, 2023 Indirect
ALUMIS INC. 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 Jul 1, 2024 Indirect
ALUMIS INC. 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Jul 1, 2024 Indirect
ALUMIS INC. 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Jul 1, 2024 Indirect
ALUMIS INC. 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Jul 1, 2024 Indirect
ALUMIS INC. 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 Jul 1, 2024 Indirect

Insider Reports Filed by Foresite Capital Management V, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALMS ALUMIS INC. Jul 1, 2024 32 $40M 4 Jul 3, 2024 10%+ Owner
ALMS ALUMIS INC. Jun 27, 2024 0 $0 3 Jun 27, 2024 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jul 17, 2023 2 $2.08M 4 Jul 19, 2023 10%+ Owner
PRDS PARDES BIOSCIENCES, INC. Apr 5, 2023 1 $1.16M 4 Apr 6, 2023 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Dec 29, 2022 2 $2.5M 4 Jan 3, 2023 10%+ Owner
PRDS PARDES BIOSCIENCES, INC. Dec 1, 2022 1 $542K 4 Dec 5, 2022 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jun 9, 2022 0 $0 3 Jun 13, 2022 10%+ Owner